Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fampridine Pregnancy Exposure Registry

This study has been terminated.
(Due to low enrollment, registration closed in agreement with the Regulatory Agency)
Sponsor:
Information provided by (Responsible Party):
Biogen
ClinicalTrials.gov Identifier:
NCT01532154
First received: December 15, 2011
Last updated: November 30, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)